A large number of natural products derived from traditional Chinese medicine have been shown to possess anticancer activity, including cancer cell proliferation, promotion of cancer cell apoptosis, prevention of cancer metastasis, inhibition of cancer cell angiogenesis, and regulation of cancer cell autophagy, reversal of drug resistance, balance of immune effects, and enhancement of chemotherapy efficacy.

The research team used high-throughput 3D cell screening technology to select effective combinations from thousands of traditional Chinese medicines as anti-cancer agents. Analytical chemistry has summarized dozens of effective components, including curcumin, epigallocatechin gallate, berberine, artemisinin, ginsenoside Rg3, ursodeoxycholic acid, silybin, rhubarb emodin, triptolide, berberine, tanshinone I, wintergreenin, purple rootin, artemisinin, hanceol B, and cephalosporin, etc.

Scientific research team from PubMed、Web of Science、Medline、Scopus scientific database. A complete review of pharmacological effects, new mechanisms of action, related clinical studies and their innovative clinical applications in combined therapy and immunomodulation, and the selection of formulation combinations and verification through in vitro cell and live animal experiments, and more potential in cancer clinical treatment, clinical case studies of dozens of cancer patients at advanced stages, not only significantly reduced the toxic and side effects of chemotherapy patients and significantly enhanced the efficacy, the current goal is to deeply study immunogenetic regulation and deep-seated mechanisms of action, and then define specific immun检查 point regulatory functions, optimize products for specific cancers, actively strive to enter human clinical trials, and bring hope of life to more cancer patients.